Keen baker Lucille Carter from Thorpe Willoughby in North Yorkshire has raised thousands of pounds for PCRF over the years by supporting the charity’s Bake & Share campaign each November during Pancreatic Cancer Awareness Month.
After losing her husband David to pancreatic cancer in January 2020, Marilyn Collins from Halesowen, West Midlands, and her sister Glenis Allen raised £2000 for PCRF by hand-crafting beautiful Christmas angels, repurposed from old books and magazines.
We’re keen to support early career researchers who have chosen to focus on pancreatic cancer, such as PhD student Lavanya Sivapalan from Queen Mary University of London, who carries out innovative research into liquid biopsies.
In accordance with best practice for medical research charities, we have appointed a Scientific Advisory Panel, which is made up of prominent cancer experts. They act in a voluntary capacity and ensure that the research the charity funds is of the highest quality and will lead to developments in detection and treatment of pancreatic cancer. Members […]
Professor Evans is researching a new class of anti-cancer agents, that target an enzyme family called Src Kinase. The aim is to see if these agents can stop the spread of cancer following surgery.
‘Oncolytic viruses’ are viruses that are engineered to infect and kill cancer cells and have the potential to treat many different cancers, including pancreatic. Professor Parker will use the latest specialised methods to test a new oncolytic virus his team has engineered to specifically infect pancreatic cancer cells. The infected cells are forced to produce anti-cancer medicines, attracting immune cells, and instructing them to recognise and destroy other cancer cells in the body.
Our immune system is primed to attack cancer cells as soon as they are detected. Dr Litchfield aims to develop a blood test which measures three different aspects of our body’s immune response to early stage pancreatic cancer. He believes this new approach could produce results that are more accurate and sensitive than other early detection tests currently being developed.
After 20 years of supporting research into pancreatic cancer, Pancreatic Cancer Research Fund (PCRF) has announced its intention to scale back at the end of April 2024. The charity’s CEO Maggie Blanks, who set up the charity in 2004, will retire.
Seven innovative research projects tackling pancreatic cancer have been awarded grants by the national charity Pancreatic Cancer Research Fund (PCRF) totalling £1.2M.
This project aims to develop a panel of urinary biomarkers that can be used to test for pancreatic cancer.